tiprankstipranks
RemeGen Co. Ltd. Class H (HK:9995)
:9995
Hong Kong Market
9995
RemeGen Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:9995 full AI Analyst Report?

RemeGen Co. Ltd. Class H (9995) Stock News & Sentiment

6 Followers
RemeGen Issues Unaudited 2026 First-Quarter Report and Cautions Investors
Premium
Company Announcements
RemeGen Issues Unaudited 2026 First-Quarter Report and Cautions Investors
12d ago
RemeGen Sets Board Meeting to Approve First-Quarter 2026 Results
Premium
Company Announcements
RemeGen Sets Board Meeting to Approve First-Quarter 2026 Results
24d ago
RemeGen Receives US$650 Million Upfront from AbbVie for RC148 Global Rights
Premium
Company Announcements
RemeGen Receives US$650 Million Upfront from AbbVie for RC148 Global Rights
25d ago
RemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer
Premium
Company Announcements
RemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer
30d ago
RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288
Premium
Company Announcements
RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288
1M ago
RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access
Premium
Company Announcements
RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access
1M ago
RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer
Premium
Company Announcements
RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer
2M ago
More HK:9995 News >

9995 News on the Web

RemeGen Sets Board Meeting to Approve First-Quarter 2026 Results
TipRanks News
Bullish
RemeGen Receives US$650 Million Upfront from AbbVie for RC148 Global Rights
TipRanks News
Bullish
RemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer
TipRanks News
Bullish
CICC Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
TipRanks News
Neutral
RemeGen Co. Ltd. Class H (9995) Gets a Buy from J.P. Morgan
TipRanks News
Neutral
RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288
TipRanks News
Neutral
RemeGen Co. Ltd. Class H (9995) Gets a Buy from BOCOM International Holdings Company
TipRanks News
Neutral
RemeGen Co. Ltd. Class H (9995) Gets a Buy from Bank of China
TipRanks News
Neutral

News Score - Last 7 Days

Positive
HK:9995
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:9995’s Media Buzz Sentiment?
2 articles about HK:9995 were published this week. In an average week, 2.25 articles are published.
    What is HK:9995’s weekly average amount of articles?
    In an average week, 2.25 articles about HK:9995 are published.
      What is HK:9995’s News Sentiment?
      100% of articles about HK:9995 were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week